12 Health Care Stocks Moving In Thursday's Intraday Session

Gainers

• ADiTx Therapeutics ADTX stock increased by 77.0% to $4.62 during Thursday's regular session. As of 12:32 EST, ADiTx Therapeutics's stock is trading at a volume of 104.5 million, which is 9481.88% of its average full-day volume over the last 100 days. The company's market cap stands at $56.7 million.
• BiondVax Pharmaceuticals BVXV stock rose 48.93% to $6.3. As of 12:32 EST, this security is trading at a volume of 4.9 million shares, making up 362.44% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $72.6 million.
• AzurRx BioPharma AZRX shares increased by 37.8% to $1.27. As of 12:32 EST, AzurRx BioPharma's stock is trading at a volume of 30.2 million, which is 2268.05% of its average full-day volume over the last 100 days. The company's market cap stands at $43.6 million.
• ReWalk Robotics RWLK shares increased by 34.44% to $2.69. As of 12:32 EST, ReWalk Robotics's stock is trading at a volume of 11.3 million, which is 728.3% of its average full-day volume over the last 100 days. The company's market cap stands at $66.5 million.
• Genetic Technologies GENE shares increased by 30.93% to $5.63. Trading volume for this security as of 12:32 EST is 41.5 million, which is 3723.34% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $77.5 million.
• Celsion CLSN shares rose 28.62% to $1.64. Celsion's stock is trading at a volume of 132.6 million shares as of 12:32 EST. This is 4522.07% of its average full-day volume over the last 100 days. The company's market cap stands at $61.3 million.

Losers

• Obalon Therapeutics OBLN stock decreased by 30.56% to $5.75 during Thursday's regular session. As of 12:32 EST, this security is trading at a volume of 16.4 million shares, making up 145.21% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $44.6 million.
• Cancer Genetics CGIX stock fell 26.8% to $4.29. As of 12:32 EST, Cancer Genetics's stock is trading at a volume of 1.5 million, which is 235.07% of its average full-day volume over the last 100 days. The company's market cap stands at $17.5 million.
• Dyne Therapeutics DYN stock decreased by 23.07% to $21.95. As of 12:32 EST, this security is trading at a volume of 2.4 million shares, making up 861.07% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $997.5 million.
• Caladrius Biosciences CLBS shares fell 16.96% to $2.4. The current volume of 7.6 million shares is 343.6% of Caladrius Biosciences's average full-day volume over the last 100 days (last updated at 12:32 EST). The company's market cap stands at $46.5 million.
• CytomX Therapeutics CTMX stock decreased by 16.31% to $6.83. As of 12:32 EST, CytomX Therapeutics's stock is trading at a volume of 4.3 million, which is 876.61% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $315.4 million.
• INmune Bio INMB shares fell 15.61% to $21.2. Trading volume for INmune Bio's stock is 1.9 million as of 12:32 EST. This is 1141.27% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $285.0 million.